SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-23-012906
Filing Date
2023-04-14
Accepted
2023-04-14 16:30:44
Documents
18

Document Format Files

Seq Description Document Type Size
1 PRE 14A mcrb-20230414.htm   iXBRL PRE 14A 2164723
2 GRAPHIC img114728013_0.jpg GRAPHIC 129593
3 GRAPHIC img114728013_1.jpg GRAPHIC 113814
4 GRAPHIC img114728013_2.jpg GRAPHIC 516751
5 GRAPHIC img114728013_3.jpg GRAPHIC 495560
  Complete submission text file 0000950170-23-012906.txt   6374991

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mcrb-20230414_lab.xml EX-101.LAB 16552
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mcrb-20230414_pre.xml EX-101.PRE 9792
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mcrb-20230414_def.xml EX-101.DEF 8084
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mcrb-20230414.xsd EX-101.SCH 6669
12 EXTRACTED XBRL INSTANCE DOCUMENT mcrb-20230414_htm.xml XML 382211
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37465 | Film No.: 23821570
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences